Inhibitory Effects of Bio-Energy Therapies on Cancer Growth——An overview of recent laboratory studies in the U.S. And its implications in cancer treat

Bioenergy therapies (such as Qigong, Reiki, Yoga, Pranic healing, and Therapeutic touch) have reported benefits for cancer patients, but few randomized control trials were done to verify their efficacy. It is believed that laboratory study of inhibitory effects of bio-energy therapies on cancer growth may lead to an understanding of the true efficacy of bio-energy and create a foundation for future clinical trials. Methods: Typical in-vitro study involved randomly dividing lab-prepared cancer cells into different groups with one being treated by bio-energy therapy and one or more as control groups. Sometimes, controls were treated by a sham healer. Typical in vivo study involved injecting or implanting cancerous cells into mice, then randomly dividing them into various groups. The control could be either non-treatment or sham treatment; the outcomes include tumor size or survival time. Results: Most studies demonstrated some inhibitory effects of bioenergy therapies on the growth of cancer cells in comparison with control. The in vivo studies reported that the bio-energy treated group had significantly slower tumor growth or longer survival lives than those in the control. One study reported survival with a normal life cycle instead of dying in 3 weeks, and cancer-infected mice developed immune response to the same breast cancer. However, researchers are confronted with methodological challenges in choosing appropriate controis, minimizing contamination, and replicating study outcomes. Conclusion: Encouraging evidence suggests hioenergy may have inhibitory effects on cancer growth, or prolong the life of cancer-infected animals, although improvement is needed in research design and replication of the findings. Bioenergy for cancer treatment is an area that is often neglected by mainstream medicine and research,and it should be seriously examined and considered as an important supplement to conventional cancer treatment.

Xenobiotic effects in cancer related pathways-high throughput screening and proof of concept in animal models

Cancer genomics is a rapidly growing discipline in which the genetic molecular basis of malignancy is studied at the scale of whole genomes. While the discipline has been successful with respect to identifying specific oncogenes and tumor suppressors involved in oncogenesis, it is also challenging our approach to managing patients suffering from this deadly disease. Speciifcally cancer genomics is driving clinical oncology to take a more molecular approach to diagnosis, prognostication, and treatment selection. We review here recent work undertaken in cancer genomics with an emphasis on translation of genomic ifndings. Finally, we discuss scientiifc challenges and research opportunities emerging from ifndings derived through analysis of tumors with high-depth sequencing.

益气活血汤对癌症患者生存质量的影响

Objective To investigate effect of decoction for supplementing qi and activating blood circulation on quality of life of cancer patients.Method 64 patients were randomly divided into study group (n=35)and control group(n=29),study group received decoction for supplementing qi and activating blood circulation and control group received strong white cells enhancing tablets.Result Total effective rate for study group and control group was 82.8% and 65.5% ,respectively.For study group,quality of life was improved by 45.7% ,survival rate for 1 year was 88.6% ,median survical period was 16.5 months.For control group, quality of life was improved by 31% ,survival rate for 1 year was 58.6% ,median survival period was 9.6 months.Conclusion Decoction for supplementing qi and activating blood circulation markedly improve immune function,lighten adverse and toxicological reactions,and hence improveing patients quality of life.

OBJECTIVE:The aim of this study is to analyze how patients with chronic diseases from Shanghai interpret their disease, and how these interpretations inlfuence patients’ life satisfaction, intention to escape from their illness and their ability to relfect on the implications of their illness.
METHODS:A cross-sectional study enrolling 142 patients (mean age (50 ± 16) years;63%men, 37%women) with chronic diseases (60%cancer) was recruited in the Changhai Hospital of Traditional Chinese Medicine, Shanghai, China and surveyed using standardized questionnaires.
RESULTS: Patients with chronic diseases from Shanghai interpreted their illness mostly as an Adverse Interruption of Life (55%), as a Threat/Enemy (50%), but also as a Challenge (49%), and only rarely as a Call for Help (18%) or as a Punishment (13%). Particularly fatalistic negative (i.e., Threat/Enemy, Adverse Interruption of Life) and strategy-associated disease interpretations (i.e., Relieving Break, Call for Help) were moderately associated with patients’ intention to escape from illness. In contrast, positive interpretations (i.e., something of Value, Challenge) and also the guilt-associated negative interpretation Failure were moderately related with patients’ ability to relfect on their illness. However, life satisfaction was weakly associated only with the view that il ness might be a Chal enge. Interestingly, 58%of those who would see their il ness as an Adverse Interruption (AI+) could see it also as a Challenge (Ch+). Detailed analyses showed that AI+Ch+patients differ from their AI+Ch- counterparts signiifcantly with respect to their ability to relfect life and implications of illness (F=9.1;P=0.004).
CONCLUSION: The observed interpretations of illness, particularly the negative perceptions, could be used as indicators that patients require further psychological assistance to cope with their burden. Helping AI+patients see their illness also as a Challenge, and thus develop a higher Relfection on Life Concerns, would be greatly beneifcial, and encourages further research.

HMGB1and autophagy

The word "autophagy" is derived from the Greek roots "auto" and "phagy" which mean "self" and "to eat", respectively.As a hot topic and rapidly expanding field in biology and medicine, autophagy is a process by which cytoplasmic components, including soluble macromolecules (such as nucleic acids, proteins, carbohydrates and lipids) and organelles (such as mitochondria, peroxisomes and endoplasmic reticulum) are degraded by lysosomes.There are at least three recognized types of autophagy including chaperone-mediated autophagy, microautophagy, and macroautophagy[1].

Transgelin研究新进展

胶转蛋白(TAGLN)是一种未知功能的22kDa蛋白质,被命名为SM22[1].该蛋白质曾在多种样本中被鉴别出,并在鼠p27、WS3-10、胶转蛋白和SM22的一些不同命名下对其进行了研究[2].物种间的基因和蛋白质序列高度保留,且在果蝇[3]和秀丽隐杆线虫[4]中鉴别出同源性.胶转蛋白是肌动结合蛋白钙调蛋白家族中的一种,存在于细胞骨架器官中[2].现将Transgelin研究综述表述如下.

Recently, obesity is a wel-recognized risk factor of type 2 diabetes and cardiovascular disease. There is more and more suf icient evidence that excess body weight is an avoidable cause of excess cancers including gastrointestinal, endometrial, esophageal adenocarcinoma, colorectal, postmenopausal breast, prostate, and renal cancers. The mechanism that obesity association with cancer is remains not wel understood. There be some most studied hypothesized mechanisms such as, high levels of insulin and free levels of insulin-like growth factors (IGFs), sex hormones, adipocytokines, inflammatory cytokines, c-Myc (or Myc) oncogenic transcription factor, obesity-induced hypoxia and Warburg ef ect, and so on. In the future, the potential mechanisms and conclusions in obesity associated with increased risk for developing cancer, and the underlying cel ular and molecular mechanisms wil be studied.

Cancer Complicated by Special Situations will be Handled in the Venous Thrombosis

1 CVC-thrombosisCVC-thrombosis natural history so far has not been clear explanation,such as:the causes of PE dangerous degree? Anticoagulation for preventive effect? And so on.Not related RCTs material to compare and evaluate different treatment scheme CVC-thrombosis final results.But in chnical practice,CVC-for the treatment of thrombosis and general treatment scheme of VTE same,i.e.use treatment doses of LMWH,period of treatment-at least three months.

Tissue Factor and Systemic Lupus Erythematosus Compncated by Atherosclerotic Lesions

We should grasp the entirety when studying the pathogenesis and treatment of disease.The pathogenesis of SLE pafients with atherosclerosis (AS)involves lipid infiltration,inflammatory reaction,immune injury,platelet aggregafion,thrombosis,etc,and the drug therapy includes lipid-lowering,anti-inflammatory,immunosuppression,anti-platelet,and anticoagulation based on corresponding theories.But these drugs,the effect of which is not ideal,principally aim at just part of pathological process.In fact,the AS lesioas in SLE in different pathological processes are closely linked,and therefore,it is very important to study the internal relations of different pathological processes and lookfor new therapeutic targets for blocking difierent pathological processes simultaneously,so as to improve the therapeutic efficacy.

Cancer and Thrombosis

Relationship between cancer and thromboembolic disease, the research has been going on for more than a century.Armand trousseau in 1865 first reported the formation of venous thrombosis prone patients with gastric cancer.

Is it Necessary to Screen Occult Cancers in the Patients with Idiopathic Venous Thromboembolism?

In 1865,Armand Trousseau first proposed that there was an association between cancer and thrombosis.In the last century,this association has been well recognized.

Cancer and Thrombosis

Since 1865, Aremand Trousseau first reported on the association between cancer and thrombosis. For many years, it has been recognized that venous thromboembolism (VTE) is a common occurrence in patients with malignant disease. Compared to other groups of patients with VTE the cancer population is unique because the pathogenesis of thrombosis differs, the frequency of VTE is greater and the clinical management required is more complex.

A predisposition to venous thrombosis in patients with malignancy has been first recognized by Trousseau in 1865.

Advances in cancer treatment allow women to be cured and live longer. However, the necessary chemotherapy and radiotherapy regimens have a negative impact on future fertility. Oncofertility has emerged as a new interdisciplinary field to address the issue of gonadotoxicity associated with cancer treatment and to facilitate fertility preservation, including oocyte and ovarian tissue cryopreservation. These fertility issues are often inadequately addressed, and referral rates to oncofertility centers are low. The aim of this study was to report the 3-year experience of the San Raffaele Oncofertility Unit. A total of 96 patients were referred to the Oncofertility Unit for evaluation after the diagnosis of cancer and before gonadotoxic treatment between April 2011 and June 2014. Of the 96 patients, 30 (31.2%) were affected by breast cancers, 20 (20.8%) by sarcomas, 28 (29.2%) by hematologic malignancies, 13 (13.5%) by central nervous system cancers, 3 (3.1%) by bowel tumors, 1 (1.0%) by Wilms’ tumor, and 1 (1.0%) by a thyroid tumor; 47 (49.0%) were referred for oocyte cryopreservation before starting chemotherapy, 20 (20.8%) were referred for ovarian tissue cryopreservation, and 29 (30.2%) were not recruited. The mean time between the patients’ counseling and oocyte retrieval was 15 days (range, 2–37 days). The mean time between the laparoscopic surgery and the beginning of treatment was 4 days (range, 2–10 days). The number of patients who were referred increased over time, whereas the rate of patients who were not recruited decreased, showing an improvement in referrals to the Oncofertility Unit and in the patients’ counseling and understanding. Our results indicate that an effective multidisciplinary oncofertility team is necessary for prompt referrals and treatment.

With the growing threat of malignancy to health, it is necessary to analyze cancer incidence and patient survival rates among the residents in Pudong New Area of Shanghai to formulate better cancer prevention strategies. A total of 43,613 cancer patients diagnosed between 2002 and 2006 were recruited from the Pudong New Area Cancer Registry. The incidence, observed survival rate, and relative survival rate of patients grouped by sex, age, geographic area, and TNM stage were calculated using the Kaplan-Meier, life table, and Ederer II methods, respectively. Between 2002 and 2006, cancer incidence in Pudong New Area was 349.99 per 100,000 person-years, and the 10 most frequently diseased sites were the lung, stomach, colon and rectum, liver, breast, esophagus, pancreas, brain and central nervous system, thyroid, and bladder. For patients with cancers of the colon and rectum, breast, thyroid, brain and central nervous system, and bladder, the 5-year relative survival rate was greater than 40%, whereas patients with cancers of the liver and pancreas had a 5-year relative survival rate of less than 10%. The 1-year to 5-year survival rates for patients grouped by sex, age, geographic area, and TNM stage differed significantly (al P<0.001). Our results indicate that cancer incidence and patient survival in Pudong New Area vary by tumor type, sex, age, geographic area, and TNM stage.

Metastasis is the main cause of cancer mortality. One of the initiating events of cancer metastasis of epithelial tumors is epithelial-to-mesenchymal transition (EMT), during which cells dedifferentiate from a relatively rigid cell structure/morphology to a flexible and changeable structure/morphology often associated with mesenchymal cells. The presence of EMT in human epithelial tumors is reflected by the increased expression of genes and levels of proteins that are preferentialy present in mesenchymal cels. The combined presence of these genes forms the basis of mesenchymal gene signatures, which are the foundation for classifying a mesenchymal subtype of tumors. Indeed, tumor classification schemes that use clustering analysis of large genomic characterizations, like The Cancer Genome Atlas (TCGA), have defined mesenchymal subtype in a number of cancer types, such as high-grade serous ovarian cancer and glioblastoma. However, recent analyses have shown that gene expression-based classifications of mesenchymal subtypes often do not associate with poor survival. This“paradox” can be ameliorated using integrated analysis that combines multiple data types. We recently found that integrating mRNA and microRNA (miRNA) data revealed an integrated mesenchymal subtype that is consistently associated with poor survival in multiple cohorts of patients with serous ovarian cancer. This network consists of 8 major miRNAs and 214 mRNAs. Among the 8 miRNAs, 4 are known to be regulators of EMT. This review provides a summary of these 8 miRNAs, which were associated with the integrated mesenchymal subtype of serous ovarian cancer.

Erythropoietin-producing hepatoma (EPH) receptors are considered the largest family of receptor tyrosine kinases and play key roles in physiological and pathologic processes in development and disease. EPH receptors are often overexpressed in human malignancies and are associated with poor prognosis. However, the functions of EPH receptors in epithelial-mesenchymal transition (EMT) remain largely unknown. This review depicts the relationship between EPH receptors and the EMT marker E-cadherin as wel as the crosstalk between EPH receptors and the signaling pathways involved EMT. Further discussion is focused on the clinical significance of EPH receptors as candidates for targeting in cancer therapeutics. Final y, we summarize how targeted inhibition of both EPH receptors and EMT-related signaling pathways represents a novel strategy for cancer treatment.

In the past century, there have been many attempts to treat cancer with low levels of electric and magnetic fields. We have developed noninvasive biofeedback examination devices and techniques and discovered that patients with the same tumor type exhibit biofeedback responses to the same, precise frequencies. Intrabuccal administration of 27.12 MHz radiofrequency (RF) electromagnetic fields (EMF), which are amplitude-modulated at tumor-specific frequencies, results in long-term objective responses in patients with cancer and is not associated with any significant adverse effects. Intrabuccal administration al ows for therapeutic delivery of very low and safe levels of EMF throughout the body as exemplified by responses observed in the femur, liver, adrenal glands, and lungs. In vitro studies have demonstrated that tumor-specific frequencies identified in patients with various forms of cancer are capable of blocking the growth of tumor cells in a tissue-and tumor-specific fashion. Current experimental evidence suggests that tumor-specific modulation frequencies regulate the expression of genes involved in migration and invasion and disrupt the mitotic spindle. This novel targeted treatment approach is emerging as an appealing therapeutic option for patients with advanced cancer given its excellent tolerability. Dissection of the molecular mechanisms accounting for the anti-cancer effects of tumor-specific modulation frequencies is likely to lead to the discovery of novel pathways in cancer.

Once considered a taboo topic or stigma, cancer is the number one public health enemy in the world. Once a product of an almost untouchable industry, tobacco is indisputably recognized as a major cause of cancer and a target for anticancer efforts. With the emergence of new economic powers in the world, especial y in highly populated countries such as China, air pol ution has rapidly emerged as a smoking gun for cancer and has become a hot topic for public health debate because of the complex political, economic, scientific, and technologic issues surrounding the air pollution problem. This editorial and the referred articles published in this special issue of the Chinese Journal of Cancer discuss these fundamental questions. Does air pollution cause a wide spectrum of cancers? Should air pollution be considered a necessary evil accompanying economic transformation in developing countries? Is an explosion of cancer incidence coming to China and how soon wil it arrive? What must be done to prevent this possible human catastrophe? Final y, the approaches for air pol ution control are also discussed.